| 英文名称 |
中文名称 |
CAS号 |
操作 |
| JNJ-38877605 |
6-[二氟[6-(1-甲基-1H-吡唑-4-基)-1,2,4-噻唑并[4,3-B]吡嗪-3-基]甲基]-喹啉 |
943540-75-8 |
详细
|
| GSK 3787 |
GSK-3787 |
188591-46-0 |
详细
|
| Lomitapide Mesylate |
甲磺酸洛美他派 |
202914-84-9 |
详细
|
| GSK163090 |
GSK163090 |
844903-58-8 |
详细
|
| GNE-7915 |
GNE7915 |
1351761-44-8 |
详细
|
| Epetraborole hydrochloride |
3-[[(3S)-3-(氨基甲基)-1,3-二氢-1-羟基-2,1-苯并氧杂硼戊环-7-基]氧基]-1-丙醇盐酸盐 |
1234563-16-6 |
详细
|
| EPZ015666 |
EPZ015666 |
1616391-65-1 |
详细
|
| glucagon receptor antagonists-4 |
GLUCAGON RECEPTOR ANTAGONISTS-4 |
1393124-08-7 |
详细
|
| Glesatinib |
Glesatinib |
936694-12-1 |
详细
|
| IMD-0354 |
N-[3,5-双(三氟甲基)苯基]-5-氯-2-羟基苯甲酰胺 |
978-62-1 |
详细
|
| Mozavaptan HCl |
莫扎伐普坦盐酸盐 |
138470-70-9 |
详细
|
| Methyloestrenolone |
甲基诺龙 |
514-61-4 |
详细
|
| GRA Ex-25 |
N-[4-[[[反式-4-(1,1-二甲基乙基)环己基][[[4-(三氟甲氧基)苯基]氨基]羰基]氨基]甲基]苄基]-B-丙氨酸 |
307983-31-9 |
详细
|
| IC-87114 |
2-[(6-氨基-9H-嘌呤-9-基)甲基]-5-甲基-3-(2-甲基苯基)-4(3H)-喹唑啉酮 |
371242-69-2 |
详细
|
| Hesperadin |
HESPERADIN |
422513-13-1 |
详细
|
| ISX9 |
ISX 9 |
832115-62-5 |
详细
|
| JM 6 |
JM 6 |
1008119-83-2 |
详细
|
| GENZ-644282 |
GENZ-644282 |
529488-28-6 |
详细
|
| GSK2838232 |
GSK2838232 |
1443461-21-9 |
详细
|
| Liproxstatin-1 |
利普司他丁-1 |
950455-15-9 |
详细
|
| lusutrombopag |
芦曲泊帕 |
1110766-97-6 |
详细
|
| Methylestradiol |
甲雌二醇 |
302-76-1 |
详细
|
| MRS 2578 |
MRS 2578 |
711019-86-2 |
详细
|
| Mebolazine |
美勃嗪 |
3625-07-8 |
详细
|
| Episilvestrol |
EPISILVESTROL |
697235-39-5 |
详细
|
| Indeglitazar |
INDEGLITAZAR |
835619-41-5 |
详细
|
| INCB024360-Analog |
4-氨基-N-(3-氯-4-氟苯基)-N'-羟基-1,2,5-恶二唑-3-甲脒 |
914471-09-3 |
详细
|
| HTH-01-015 |
HTH-01-015 |
1613724-42-7 |
详细
|
| GENZ-682452 |
GENZ-682452 |
1401090-53-6 |
详细
|
| MS-275 |
恩替诺特 |
209783-80-2 |
详细
|
| Marimastat |
马立马司他 |
154039-60-8 |
详细
|
| Nocodazole |
诺考达唑 |
31430-18-9 |
详细
|
| GSK-1120212 |
曲美替尼 |
871700-17-3 |
详细
|
| IEM 1754 dihydrobromide |
IEM 1754 DIHYDROBROMIDE |
162831-31-4 |
详细
|
| GDC-0980 |
(S)-1-[4-[[2-(2-氨基嘧啶-5-基)-7-甲基-4-(吗啉-4-基)噻吩并[3,2-D]嘧啶-6-基]甲基]哌嗪-1-基]-2-羟基丙-1-酮 |
1032754-93-0 |
详细
|
| Irbinitinib |
妥卡替尼 |
937263-43-9 |
详细
|
| GLPG0634 analog |
GLPG0634 |
1206101-20-3 |
详细
|
| MG-132 |
MG132,蛋白酶体抑制剂 |
133407-82-6 |
详细
|
| GSK591 |
GSK591 (EPZ-015866) |
1616391-87-7 |
详细
|
| GSK2578999A |
|
|
详细
|
| Minodronic acid |
米诺磷酸 |
180064-38-4 |
详细
|
| laxogenin |
拉肖皂苷元 |
1177-71-5 |
详细
|
| GW0742 |
GW0742 |
317318-84-6 |
详细
|
| Mepirizole |
依匹唑 |
18694-40-1 |
详细
|
| GDC-0941 |
GDC-0941 |
957054-30-7 |
详细
|
| GSK1070916 |
GSK1070916 |
942918-07-2 |
详细
|
| GW-788388 |
GW788388 |
452342-67-5 |
详细
|
| GSK 525762A |
(4S)-6-(4-氯苯基)-N-乙基-8-甲氧基-1-甲基-4H-[1,2,4]三唑并[4,3-A][1,4]苯并二氮杂卓-4-乙酰胺 |
1260907-17-2 |
详细
|
| GSK2141795 |
UPROSERTIB |
1047634-65-0 |
详细
|
| IKK epsilon-IN-1 |
CS-1801 |
1292310-49-6 |
详细
|
| EW-7197 |
EW-7197 |
1352608-82-2 |
详细
|
| INCB-024360 |
艾卡哚司他 |
1204669-58-8 |
详细
|
| NMS-P118 |
2-[1-(4,4-二氟环己基)-4-哌啶基]-6-氟-2,3-二氢-3-氧代-1H-异吲哚-4-甲酰胺 |
1262417-51-5 |
详细
|
| MITRAGYNINE PICRATE |
帽柱木碱盐酸盐 |
4098-40-2 |
详细
|
| GSK-2636771 |
GSK2636771 |
1372540-25-4 |
详细
|
| Ebselen |
依布硒 |
60940-34-3 |
详细
|
| Guanoclor |
胍氯酚 |
5001-32-1 |
详细
|
| N,N-Dipropyltryptaminehydrochloride |
N,N-二丙基色胺盐酸盐 |
7558-73-8 |
详细
|
| MDV 3100 |
恩杂鲁胺 |
915087-33-1 |
详细
|
| Linsitinib |
顺式-3-[8-氨基-1-(2-苯基-7-喹啉基)咪唑并[1,5-A]吡嗪-3-基]-1-甲基环丁醇 |
867160-71-2 |
详细
|
| GSK369796 |
GSK369796 |
1010411-21-8 |
详细
|
| GSK-189254 |
6-[(3-环丁基-2,3,4,5-四氢-1H-3-苯并氮杂卓-7-基)氧基]-N-甲基-3-吡啶甲酰胺盐酸盐 |
945493-87-8 |
详细
|
| GNF 5837 |
GNF 5837 |
1033769-28-6 |
详细
|
| MCC950 |
N-[[(1,2,3,5,6,7-六氢-S-引达省-4-基)氨基]羰基]-4-(1-羟基-1-甲基乙基)-2-呋喃磺酰胺单钠盐 |
256373-96-3 |
详细
|
| MS023 |
N1-甲基-N1-[[4-[4-(异丙氧基)苯基]-1H-吡咯-3-基]甲基]-1,2-乙二胺 |
1831110-54-3 |
详细
|
| MK-4101 |
5-(3,3-二氟环丁基)-3-[4-[4-甲基-5-[2-(三氟甲基)苯基]-4H-1,2,4-三唑-3-基]双环[2.2.2]辛烷-1-基]-1,2,4-恶二唑 |
935273-79-3 |
详细
|
| GW9508 |
885101-89-3(GW9508) |
885101-89-3 |
详细
|
| Netupitant |
奈妥吡坦 |
290297-26-6 |
详细
|
| MK-8776 |
6-溴-3-(1-甲基-1H-吡唑-4-基)-5-(3R)-3-哌啶基吡唑并[1,5-A]嘧啶-7-胺 |
891494-63-6 |
详细
|
| GSK1838705A |
GSK1838705A |
1116235-97-2 |
详细
|
| GSK-503 |
化合物GSK503 |
1346572-63-1 |
详细
|
| ML 324 |
ML324 |
1222800-79-4 |
详细
|
| Ezutromid |
依珠曲米 |
945531-77-1 |
详细
|
| GNE-495 |
GNE-495 |
1449277-10-4 |
详细
|
| MK-1775 |
MK-1775 |
955365-80-7 |
详细
|
| FG-4592 |
罗沙司他 |
808118-40-3 |
详细
|
| methyl 2-((1R,4R)-4-((tert-butoxycarbonyl)amino)cyclopent-2-en-1-yl)acetate |
帕拉米韦中间体2 |
229613-93-8 |
详细
|
| Icotinib |
埃克替尼 |
610798-31-7 |
详细
|
| LDK378 |
色瑞替尼 |
1032900-25-6 |
详细
|
| EPZ-6438 |
EPZ-6438 |
1403254-99-8 |
详细
|
| ML-281 |
ML281 |
1404437-62-2 |
详细
|
| Epetraborole |
CS-2375 |
1093643-37-8 |
详细
|
| E7449 |
E7449 |
1140964-99-3 |
详细
|
| EAI045 |
EAI-045 |
1942114-09-1 |
详细
|
| KU-55933 |
2-吗啉-4-基-6-噻蒽-1-基吡喃-4-酮 |
587871-26-9 |
详细
|
| Monastrol |
MONASTROL |
329689-23-8 |
详细
|
| GSK-2126458 |
GSK2126458 |
1086062-66-9 |
详细
|
| INK-128 |
3-(2-氨基-5-苯并恶唑基)-1-(1-甲基乙基)-1H-吡唑并[3,4-D]嘧啶-4-胺 |
1224844-38-5 |
详细
|
| INCB28060 |
卡马替尼 |
1029712-80-8 |
详细
|
| LGD-4033 |
LGD4033 |
1165910-22-4 |
详细
|
| GS9620 |
GS9620 |
1228585-88-3 |
详细
|
| IKK-16 |
IKK-16 |
873225-46-8 |
详细
|
| GNE-317 |
GNE-317 |
1394076-92-6 |
详细
|
| entrecitinib |
恩曲替尼 |
1108743-60-7 |
详细
|
| GDC-0084 |
GDC-0084 |
1382979-44-3 |
详细
|
| HA15 |
HA-15 |
1609402-14-3 |
详细
|
| ML385 |
ML385 |
846557-71-9 |
详细
|
| methyl(E)-3-(4-hydroxy-2-methoxyphenyl)propenoate |
|
162662-73-9 |
详细
|
| JTC-801 |
N-(4-氨基-2-甲基-6-喹啉基)-2-[(4-乙基苯氧基)甲基]苯甲酰胺盐酸盐 |
244218-51-7 |
详细
|
| Elacridar |
依克立达 |
143664-11-3 |
详细
|